In the US, Cerivastatin (cerivastatin systemic) is a member of the drug class statins and is used to treat High Cholesterol and Hyperlipoproteinemia Type IIa - Elevated LDL.
US matches:
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
C10AA06
CAS registry number (Chemical Abstracts Service)
0145599-86-6
Chemical Formula
C26-H34-F-N-O5
Molecular Weight
459
Therapeutic Category
Antilipemic agent, HMG CoA reductase inhibitor (statin)
Chemical Name
6-Heptenoic acid, 7-[4-(4-fluorophenyl)-5-(methoxymethyl)-2,6-bis(1-methylethyl)-3-pyridinyl]-3,5-dihydroxy-[S-[R*,S*-(E)]]-
Foreign Names
- Cerivastatinum (Latin)
- Cerivastatin (German)
- Cérivastatine (French)
- Cerivastatina (Spanish)
Generic Names
- Cerivastatin (OS: BAN)
- Cérivastatine (OS: DCF)
- Cerivastatin Sodium (OS: BANM, USAN)
- Bay W 6228 (IS: Bayer)
Brand Names
- Lipobay
Bayer, United Arab Emirates; Bayer, Bahrain; Bayer, Cyprus; Bayer, Egypt; Bayer, Iran; Bayer, Jordan; Bayer, Kenya; Bayer, Kuwait; Bayer, Lebanon; Bayer, Qatar; Bayer, Saudi Arabia; Bayer, Sudan; Bayer, Tanzania; Bayer, Uganda; Bayer Yakuhin, Japan
International Drug Name Search
Glossary
BAN | British Approved Name |
BANM | British Approved Name (Modified) |
DCF | Dénomination Commune Française |
IS | Inofficial Synonym |
OS | Official Synonym |
Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
USAN | United States Adopted Name |
Click for further information on drug naming conventions and
International Nonproprietary Names.